{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:49:20Z","timestamp":1784180960808,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study aimed to explore the spatial distribution of brain metastases (BMs) from small cell lung cancer (SCLC) a homogenous sample, and to identify the metastatic risk levels in brain regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>T1-enhanced magnetic resonance imaging (MRI) from SCLC patients were retrospectively reviewed from three medical institutions in China. All images were registered to the standard brain template provided by the Montreal Neurological Institute (MNI) 152 database, followed by transformation of the location of all BMs to the space of standard brain. The MNI structural atlas and Anatomical Automatic Labeling (AAL) atlas were then used to identify the anatomical brain regions, and the observed and expected rates of BMs were compared using 2-tailed proportional hypothesis testing. The locations and sizes of brain lesions were analyzed after image standardization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 215 eligible patients with 1033 lesions were screened by MRI, including 157 (73%) males and 58 (27%) females. The incidence of crucial structures were as follows: hippocampus 0.68%, parahippocampal 0.97%, brainstem 2.05%, cauate 0.68%, putamen 0.68%, pallidum 0.2%, thalamus 1.36%. No BMs were found in the amygdala, pituitary gland, or pineal gland. The cumulative frequency of the important structures was 6.62%. Based on the results of MNI structural atlas, the cerebellum, deep white matter and brainstem was identified as a higher risk region than expected for BMs (<jats:italic>P<\/jats:italic>\u2009=\u20099.80 \u00d710<jats:sup>\u221215<\/jats:sup>, 9.04 \u00d710<jats:sup>\u22126<\/jats:sup>), whereas temporal lobe were low-risk regions (<jats:italic>P<\/jats:italic>\u2009=\u20091.65 \u00d710<jats:sup>\u22124<\/jats:sup>). More detailed AAL atlas revealed that the low-risk regions for BMs was inferior frontal gyrus (<jats:italic>P<\/jats:italic>\u2009=\u20096.971 \u00d710<jats:sup>\u22124<\/jats:sup>), while the high-risk regions for BMs was cerebellar hemispheres (<jats:italic>P<\/jats:italic>\u2009=\u20091.177 \u00d710<jats:sup>\u22129<\/jats:sup>).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Many crucial structures including the hippocampus, parahippocampus, pituitary gland and thalamus etc. have low frequency of brain metastases in a population of SCLC patients. This study provides the help to investigate the clinical feasibility of HA-WBRT and non-uniform dose of PCI in a population of SCLC patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-021-00410-w","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T21:02:27Z","timestamp":1623618147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,13]]},"reference":[{"issue":"1","key":"410_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"AS Achrol","year":"2019","unstructured":"Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, et al. Brain metastases. Nat Rev Dis Primers. 2019;5(1):5. https:\/\/doi.org\/10.1038\/s41572-018-0055-y.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"410_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","volume":"35","author":"HH Popper","year":"2016","unstructured":"Popper HH. Progression and metastasis of lung cancer. Cancer Metastasis Rev. 2016;35(1):75\u201391. https:\/\/doi.org\/10.1007\/s10555-016-9618-0.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"410_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","volume":"3","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, et al. Estimating survival in patients with lung cancer and brain metastases. JAMA Oncol. 2017;3(6):827\u201331. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3834.","journal-title":"JAMA Oncol"},{"issue":"3","key":"410_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/jnci\/87.3.183","volume":"87","author":"R Arriagada","year":"1995","unstructured":"Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 1995;87(3):183\u201390. https:\/\/doi.org\/10.1093\/jnci\/87.3.183.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"410_CR5","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S1470-2045(16)30065-1","volume":"17","author":"CL P\u00e9choux","year":"2016","unstructured":"P\u00e9choux CL, Sun A, Slotman BJ, de Ruysscher D, Belderbos J, Gore EM. Prophylactic cranial irradiation for patients with lung cancer. Lancet Oncol. 2016;17(7):e277\u201393. https:\/\/doi.org\/10.1016\/S1470-2045(16)30065-1.","journal-title":"Lancet Oncol"},{"issue":"3","key":"410_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","volume":"10","author":"CB Simone 2nd","year":"2020","unstructured":"Simone CB 2nd, Bogart JA, Cabrera AR, et al. Radiation therapy for small cell lung cancer: an astro clinical practice guideline. Pract Radiat Oncol. 2020;10(3):158\u201373. https:\/\/doi.org\/10.1016\/j.prro.2020.02.009.","journal-title":"Pract Radiat Oncol"},{"issue":"10","key":"410_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1200\/JCO.2006.09.2536","volume":"25","author":"J Li","year":"2007","unstructured":"Li J, Bentzen SM, Renschler M, Mehta MP. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 2007;25(10):1260\u20136. https:\/\/doi.org\/10.1200\/JCO.2006.09.2536.","journal-title":"J Clin Oncol"},{"issue":"34","key":"410_CR8","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","volume":"32","author":"V Gondi","year":"2014","unstructured":"Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (rtog 0933): a phase ii multi-institutional trial. J Clin Oncol. 2014;32(34):3810\u20136. https:\/\/doi.org\/10.1200\/JCO.2014.57.2909.","journal-title":"J Clin Oncol"},{"issue":"10","key":"410_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1200\/JCO.19.02767","volume":"38","author":"PD Brown","year":"2020","unstructured":"Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, et al. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase iii trial nrg oncology cc001. J Clin Oncol. 2020;38(10):1019\u201329. https:\/\/doi.org\/10.1200\/JCO.19.02767.","journal-title":"J Clin Oncol"},{"key":"410_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fonc.2019.00991","volume":"9","author":"J Jaspers","year":"2019","unstructured":"Jaspers J, Mendez Romero A, Hoogeman MS, et al. Evaluation of the hippocampal normal tissue complication model in a prospective cohort of low grade glioma patients-an analysis within the eortc 22033 clinical trial. Front Oncol. 2019;9:991. https:\/\/doi.org\/10.3389\/fonc.2019.00991.","journal-title":"Front Oncol"},{"issue":"1","key":"410_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-012-0937-x","volume":"110","author":"CC Quattrocchi","year":"2012","unstructured":"Quattrocchi CC, Errante Y, Gaudino C, Mallio CA, Giona A, Santini D, et al. Spatial brain distribution of intra-axial metastatic lesions in breast and lung cancer patients. J Neuro-Oncol. 2012;110(1):79\u201387. https:\/\/doi.org\/10.1007\/s11060-012-0937-x.","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"410_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188542","volume":"12","author":"S Kyeong","year":"2017","unstructured":"Kyeong S, Cha YJ, Ahn SG, Suh SH, Son EJ, Ahn SJ. Subtypes of breast cancer show different spatial distributions of brain metastases. PLoS One. 2017;12(11):e0188542. https:\/\/doi.org\/10.1371\/journal.pone.0188542.","journal-title":"PLoS One"},{"issue":"5","key":"410_CR13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/neuonc\/noz023","volume":"21","author":"TK Yanagihara","year":"2019","unstructured":"Yanagihara TK, McFaline-Figueroa JR, Giacalone NJ, et al. A low percentage of metastases in deep brain and temporal lobe structures. Neuro-Oncology. 2019;21(5):640\u20137. https:\/\/doi.org\/10.1093\/neuonc\/noz023.","journal-title":"Neuro-Oncology"},{"issue":"5","key":"410_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/neuonc\/nov266","volume":"18","author":"K Takano","year":"2016","unstructured":"Takano K, Kinoshita M, Takagaki M, Sakai M, Tateishi S, Achiha T, et al. Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor. Neuro-Oncology. 2016;18(5):716\u201324. https:\/\/doi.org\/10.1093\/neuonc\/nov266.","journal-title":"Neuro-Oncology"},{"issue":"1412","key":"410_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1098\/rstb.2001.0915","volume":"356","author":"J Mazziotta","year":"2001","unstructured":"Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, et al. A probabilistic atlas and reference system for the human brain: international consortium for brain mapping (icbm). Philos Trans R Soc Lond Ser B Biol Sci. 2001;356(1412):1293\u2013322. https:\/\/doi.org\/10.1098\/rstb.2001.0915.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"2","key":"410_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, et al. Fsl. Neuroimage. 2012;62(2):782\u201390. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.09.015.","journal-title":"Neuroimage"},{"issue":"1","key":"410_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in spm using a macroscopic anatomical parcellation of the mni mri single-subject brain. Neuroimage. 2002;15(1):273\u201389. https:\/\/doi.org\/10.1006\/nimg.2001.0978.","journal-title":"Neuroimage"},{"issue":"1","key":"410_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.18383\/j.tom.2016.00268","volume":"3","author":"TK Yanagihara","year":"2017","unstructured":"Yanagihara TK, Lee A, Wang TJC. Quantitative analysis of the spatial distribution of metastatic brain lesions. Tomography. 2017;3(1):16\u201322. https:\/\/doi.org\/10.18383\/j.tom.2016.00268.","journal-title":"Tomography"},{"issue":"9","key":"410_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrclinonc.2017.71","volume":"14","author":"JK Sabari","year":"2017","unstructured":"Sabari JK, Lok BH, Laird JH, Poirier JT, Rudin CM. Unravelling the biology of sclc: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549\u201361. https:\/\/doi.org\/10.1038\/nrclinonc.2017.71.","journal-title":"Nat Rev Clin Oncol"},{"issue":"34","key":"410_CR20","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1200\/JCO.2009.27.0140","volume":"28","author":"AM Ruppert","year":"2010","unstructured":"Ruppert AM, Stankoff B, Lavole A, et al. Miliary brain metastases in lung cancer. J Clin Oncol. 2010;28(34):e714\u20136. https:\/\/doi.org\/10.1200\/JCO.2009.27.0140.","journal-title":"J Clin Oncol"},{"issue":"5","key":"410_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1200\/JCO.2017.75.9589","volume":"36","author":"PD Brown","year":"2018","unstructured":"Brown PD, Ahluwalia MS, Khan OH, Asher AL, Wefel JS, Gondi V. Whole-brain radiotherapy for brain metastases: evolution or revolution? J Clin Oncol. 2018;36(5):483\u201391. https:\/\/doi.org\/10.1200\/JCO.2017.75.9589.","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"410_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/annonc\/11.suppl_3.101","volume":"11","author":"A Ardizzoni","year":"2000","unstructured":"Ardizzoni A, Grossi F. Update on the treatment of small cell lung cancer (sclc). Ann Oncol. 2000;11(Suppl 3):101\u20138. https:\/\/doi.org\/10.1093\/annonc\/11.suppl_3.101.","journal-title":"Ann Oncol"},{"issue":"2","key":"410_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cllc.2017.08.004","volume":"19","author":"A Halthore","year":"2018","unstructured":"Halthore A, Goenka A, Sharma R, Knisely JPS. Prophylactic cranial irradiation for resectable small-cell lung cancer. Clin Lung Cancer. 2018;19(2):115\u20139. https:\/\/doi.org\/10.1016\/j.cllc.2017.08.004.","journal-title":"Clin Lung Cancer"},{"key":"410_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/LCTT.S137577","volume":"9","author":"F Manapov","year":"2018","unstructured":"Manapov F, Kasmann L, Roengvoraphoj O, et al. Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes. Lung Cancer (Auckl). 2018;9:49\u201355. https:\/\/doi.org\/10.2147\/LCTT.S137577.","journal-title":"Lung Cancer (Auckl)"},{"issue":"9804","key":"410_CR25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","volume":"378","author":"JP van Meerbeeck","year":"2011","unstructured":"van Meerbeeck JP, Fennell DA, De Ruysscher DKM. Small-cell lung cancer. Lancet. 2011;378(9804):1741\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(11)60165-7.","journal-title":"Lancet"},{"issue":"2","key":"410_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cllc.2016.09.007","volume":"18","author":"R Zhao","year":"2017","unstructured":"Zhao R, Kong W, Shang J, Zhe H, Wang YY. Hippocampal-sparing whole-brain radiotherapy for lung cancer. Clin Lung Cancer. 2017;18(2):127\u201331. https:\/\/doi.org\/10.1016\/j.cllc.2016.09.007.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"410_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ijrobp.2017.03.009","volume":"98","author":"KJ Redmond","year":"2017","unstructured":"Redmond KJ, Hales RK, Anderson-Keightly H, Zhou XC, Kummerlowe M, Sair HI, et al. Prospective study of hippocampal-sparing prophylactic cranial irradiation in limited-stage small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;98(3):603\u201311. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.009.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"410_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijrobp.2020.02.029","volume":"107","author":"H Vees","year":"2020","unstructured":"Vees H, Caparrotti F, Eboulet EI, et al. Impact of early prophylactic cranial irradiation with hippocampal avoidance on neurocognitive function in patients with limited disease small cell lung cancer. A multicenter phase 2 trial (sakk 15\/12). Int J Radiat Oncol Biol Phys. 2020;107:279\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"41","key":"410_CR29","doi-asserted-by":"publisher","first-page":"44030","DOI":"10.18632\/oncotarget.5828","volume":"6","author":"SG Wu","year":"2015","unstructured":"Wu SG, Rao MY, Zhou J, Lin Q, Wang ZJ, Chen YX, et al. Distribution of metastatic disease in the brain in relation to the hippocampus: a retrospective single-center analysis of 6064 metastases in 632 patients. Oncotarget. 2015;6(41):44030\u20136. https:\/\/doi.org\/10.18632\/oncotarget.5828.","journal-title":"Oncotarget"},{"issue":"3","key":"410_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ijrobp.2014.03.019","volume":"89","author":"M Kalm","year":"2014","unstructured":"Kalm M, Abel E, Wasling P, Nyman J, Hietala MA, Bremell D, et al. Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys. 2014;89(3):607\u201314. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.03.019.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"410_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijrobp.2010.05.013","volume":"81","author":"AH Wolfson","year":"2011","unstructured":"Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase ii randomized trial radiation therapy oncology group (rtog) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81:77\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"410_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40644-020-00309-y","volume":"20","author":"B Lin","year":"2020","unstructured":"Lin B, Huang D, Yang X, Zhang Y, Gang F, du XB. Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy. Cancer Imaging. 2020;20(1):29. https:\/\/doi.org\/10.1186\/s40644-020-00309-y.","journal-title":"Cancer Imaging"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-021-00410-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-021-00410-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-021-00410-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T21:10:20Z","timestamp":1623618620000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-021-00410-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,13]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1186\/s40644-021-00410-w","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,13]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Shandong Cancer Hospital and Institute, Fudan University Shanghai Cancer Center, and Linyi People\u2019s Hospital, and informed consent was waived due to the retrospective character of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}